Propanc Biopharma Files S-1/A Amendment
Ticker: PPCB · Form: S-1/A · Filed: Apr 25, 2025 · CIK: 1517681
| Field | Detail |
|---|---|
| Company | Propanc Biopharma, Inc. (PPCB) |
| Form Type | S-1/A |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, pharmaceutical, amendment
TL;DR
Propanc Biopharma filed an S-1/A. Check financials.
AI Summary
Propanc Biopharma, Inc. filed an S-1/A amendment on April 25, 2025, detailing its financial status and business operations. The company, previously known as Propanc Health Group Corp, is incorporated in Delaware and operates in the pharmaceutical preparations sector. Its fiscal year ends on June 30th, with its principal business address located in Camberwell, Victoria, Australia.
Why It Matters
This filing provides updated information for investors and the public regarding Propanc Biopharma's financial health and strategic direction in the pharmaceutical industry.
Risk Assessment
Risk Level: medium — As a pharmaceutical company with an S-1/A filing, there's inherent risk associated with clinical trials, regulatory approvals, and market adoption of its products.
Key Players & Entities
- Propanc Biopharma, Inc. (company) — Filer of the S-1/A
- Propanc Health Group Corp (company) — Former name of Propanc Biopharma, Inc.
- 20250425 (date) — Filing date of the S-1/A
- 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 (address) — Business and mailing address
- 61-03-9882-0780 (phone_number) — Business phone number
FAQ
What is the primary business of Propanc Biopharma, Inc.?
Propanc Biopharma, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.
When was the company formerly known as Propanc Health Group Corp?
The company changed its name from Propanc Health Group Corp on April 8, 2011.
What is the fiscal year end for Propanc Biopharma, Inc.?
The fiscal year end for Propanc Biopharma, Inc. is June 30th.
In which state is Propanc Biopharma, Inc. incorporated?
Propanc Biopharma, Inc. is incorporated in Delaware (DE).
What is the accession number for this S-1/A filing?
The accession number for this filing is 0001641172-25-006154.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on April 25, 2025 regarding Propanc Biopharma, Inc. (PPCB).